Onwards and upwards! 💪🔬 research fuels scientific progress and innovation, so grateful to the Andy Hill CARE Fund in recognizing this 😊
🚀 Exciting news! #MC3Institute is now on Bluesky!
We’re a new institute dedicated to improving the lives of Merkel cell carcinoma #MCC patients through translational research. Follow us for updates, latest research, & collaboration opportunities. Learn more at mc3institute.uw.edu! #CancerResearch
Get those blood tests (AMERK and ctDNA) going for MCC patients! Super helpful for surveillance and early recurrence detection, and provides a lot of peace of mind for both patients and clinicians.
@mc3-institute.bsky.social @paulnghiem.bsky.social
@lachancekrista.bsky.social
Dr. Peter Ch’en, MD, MPH 🎓🩺
Thank you @einsteinmededu.bsky.social for the experience of a lifetime - I’ll keep the lessons from the BX close.
Catch me as a dermatologist *soon*! Back to Seattle @uwdermatology.bsky.social I go.
To my community who kept me going - we did this together. Thank you.
Peter Ch’en
Merkel Cell Carcinoma Collaborative (MC3) Institute
Peter Ch’en
Peter Ch’en
Proud to share the #NghiemLab & #MC3Institute received a $1.3m grant from the Andy Hill Cancer Research Endowment #CAREFund to support 2 projects focused on advancing Merkel cell carcinoma #MCC research.
🔗 mc3institute.uw.edu/news/nghiem-lab-mc3-institute-awarded-1.3-million-cancer-research
In this cohort study of Merkel cell #carcinoma patients, a falling or negative titer indicated a 99.3% chance of remaining recurrence-free over 3 months, while a rising oncoprotein antibody titer suggested a 58% risk of recurrence by 12 months. ja.ma/4rifJeA
Merkel Cell Carcinoma Collaborative (MC3) Institute
